Cartesian Therapeutics
RNAC
#6811
Rank
โ‚น41.05 B
Marketcap
โ‚น1,615
Share price
-1.30%
Change (1 day)
-9.33%
Change (1 year)

Cartesian Therapeutics (RNAC) - Cash on Hand

Cash on Hand as of September 2024 : โ‚น18.61 Billion

According to Cartesian Therapeutics's latest financial reports the company has โ‚น18.61 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cartesian Therapeutics - Cash on Hand chart (from 2015 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น6.40 B-42.52%
2022-12-31โ‚น11.13 B16.86%
2021-12-31โ‚น9.53 B-6.03%
2020-12-31โ‚น10.14 B58.22%
2019-12-31โ‚น6.41 B145.11%
2018-12-31โ‚น2.61 B-57.62%
2017-12-31โ‚น6.17 B7.92%
2016-12-31โ‚น5.71 B135.97%
2015-12-31โ‚น2.42 B130.43%
2014-12-31โ‚น1.05 B